NDC 87735-002 - SULISRx Sunburn Relief Kit
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87735-002
- Package NDCs from labels
- 87735-002-01
- Manufacturer
- Sephoris Pharmaceuticals, LLC | Blaine Labs, Inc. | Finecure Pharmaceuticals LTD
- Effective date
- 2026-09-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SULISRx Sunburn Relief Kit - Sephoris Pharmaceuticals, LLC | Blaine Labs, Inc. | Finecure Pharmaceuticals LTD | Sephoris Pharmaceuticals, LLC | Blaine Labs, Inc. | Finecure Pharmaceuticals LTD | 2026-09-19 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PURELL Professional Advanced Hand Sanitizer Fragrance Free Gel | ALCOHOL | GOJO Industries, Inc. | 4952bb21-fefa-4ae1-8e1a-feb412ce100c | 2025-12-19 | Warnings | 3K9958V90M |
| Night Time Multi-Symptom Cold and Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Discount Drug Mart | 8148c2b1-f6ec-4597-8e18-a6597cda5705 | 2025-12-19 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | NUVICARE LLC | 591ee107-e953-4982-b75f-13a0afd7c4ae | 2025-12-19 | Warnings | 362O9ITL9D |
| Radiant Defense Perfecting Liquid Broad Spectrum SPF 30 - Shell | TITANIUM DIOXIDE, ZINC OXIDE | Rodan & Fields | 12c63195-8707-4df0-a4d3-6f31c543db7a | 2025-12-19 | Warnings | 15FIX9V2JP |
| Nuvicare Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | NUVICARE LLC | 3ede0fb6-c089-4253-9878-2b01c39e9c87 | 2025-12-19 | Warnings | 362O9ITL9D |
| Aspercreme with Lidocaine Foot Pain Creme | LIDOCAINE HYDROCHLORIDE | Chattem, Inc. | da82cc0e-cc39-408e-87e1-c35bb6f9f51e | 2025-12-19 | Warnings | V13007Z41A |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | NUVICARE LLC | 95edf7bd-b6a7-4be5-9ad7-8748e7c2d06e | 2025-12-19 | Warnings | 362O9ITL9D |
| Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE | NUVICARE LLC | 32a5611b-9bf6-4850-a7ff-fa240da04f45 | 2025-12-19 | Warnings | 362O9ITL9D |
| Somineze | HUMULUS LUPULUS, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, AMBROSIA ARTEMISIAEFOLIA, ARSENICUM ALBUM, COFFEA TOSTA, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, SILICEA | BioActive Nutritional, Inc. | c0f80b84-0dd5-416b-abdf-8a0412e0b40b | 2025-12-18 | Warnings | ETJ7Z6XBU4 |
| SUNSCREEN SPRAY150mL | ZINC OXIDE 12%, TITANIUM DIOXIDE 6%, HOMOSALATE 14%, OCTISALATE 5% | Foshan Sugar Max Cosmetics CO.,Ltd | 4635f90a-bbc9-0676-e063-6394a90a9f35 | 2025-12-18 | Warnings | 15FIX9V2JP |
| NARS PURE RADIANT TINTED MOISTURIZER Cuzco | OCTINOXATE, TITANIUM DIOXIDE | NARS Cosmetics | 5bb5d035-16d9-4843-b9aa-d30730c88508 | 2025-12-18 | Warnings | 15FIX9V2JP |
| NeoTuss Plus | DEXTROMETHORPHAN HBR, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | 2fabd782-14dc-1d1b-e063-6394a90af428 | 2025-12-18 | Warnings | V1Q0O9OJ9Z |
| NeoTuss Plus | DEXTROMETHORPHAN HBR, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | 2f3c6b38-7236-899b-e063-6294a90aabde | 2025-12-18 | Warnings | V1Q0O9OJ9Z |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 38560997-cfe4-2f9b-e063-6394a90a834b | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| PSSI E-San | ALCOHOL | Safe Foods Chemical Innovations | b688591a-8eea-f1ac-e053-2995a90aabac | 2025-12-18 | Warnings | 3K9958V90M |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 3f2c33e5-290e-2f89-e063-6394a90aee69 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42caf92e-6fa9-5bd7-e063-6294a90a3904 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42d9e4cf-ca73-ec6d-e063-6394a90ae937 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 3f2bdb1f-f1c0-370d-e063-6294a90a5c50 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.